Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Mitchell

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Cardio-Oncology (London, England)|February 14, 2026
Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissueJunwei Du, Leland C Sudlow, Kiana Shahverdi, et al.
JACC. Cardiooncology|December 7, 2020
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac AmyloidosisKathleen W Zhang, Jennifer Miao, Joshua D Mitchell, et al.
Cardio-Oncology (London, England)|July 3, 2025
Atrial fibrillation is associated with increased in-hospitality mortality during Chimeric Antigen Receptor T-cell therapy hospitalizations: a retrospective cohort study in the United StatesNischit Baral, Nabin R Karki, Daniel A Ladin, et al.
JACC. Cardiooncology|June 17, 2026
Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art ReviewKatelyn M Atkins, Gerard Walls, Andriana P Nikolova, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 30, 2008
High incidence of cytomegalovirus disease in D+/R- heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxisSachin Gupta, Joshua D Mitchell, David W Markham, et al.
European Heart Journal|May 27, 2026
Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiariesRaja Zaghlol, Elena Deych, Daniel A Ladin, et al.
Cancer Epidemiology|January 31, 2025
Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020Nischit Baral, Elena Deych, Deepak Chandramohan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Utility of the Cylex assay in cardiac transplant recipientsSachin Gupta, Joshua D Mitchell, David W Markham, et al.
Chest|February 13, 2016
Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk ScoreDavid C Hostler, Elizabeth S Marx, Lisa K Moores, et al.
Journal of the American Heart Association|December 23, 2025
Bio-Adrenomedullin Predicts Death and Major Adverse Cardiovascular Events in Cardiac Amyloidosis: A Cross-Continental Multicenter StudyMaximilian L Müller, Fabian Knebel, Katrin Hahn, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Cardio-Oncology (London, England)|February 14, 2026
Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissueJunwei Du, Leland C Sudlow, Kiana Shahverdi, et al.
JACC. Cardiooncology|December 7, 2020
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac AmyloidosisKathleen W Zhang, Jennifer Miao, Joshua D Mitchell, et al.
Cardio-Oncology (London, England)|July 3, 2025
Atrial fibrillation is associated with increased in-hospitality mortality during Chimeric Antigen Receptor T-cell therapy hospitalizations: a retrospective cohort study in the United StatesNischit Baral, Nabin R Karki, Daniel A Ladin, et al.
JACC. Cardiooncology|June 17, 2026
Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art ReviewKatelyn M Atkins, Gerard Walls, Andriana P Nikolova, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 30, 2008
High incidence of cytomegalovirus disease in D+/R- heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxisSachin Gupta, Joshua D Mitchell, David W Markham, et al.
European Heart Journal|May 27, 2026
Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiariesRaja Zaghlol, Elena Deych, Daniel A Ladin, et al.
Cancer Epidemiology|January 31, 2025
Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020Nischit Baral, Elena Deych, Deepak Chandramohan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Utility of the Cylex assay in cardiac transplant recipientsSachin Gupta, Joshua D Mitchell, David W Markham, et al.
Chest|February 13, 2016
Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk ScoreDavid C Hostler, Elizabeth S Marx, Lisa K Moores, et al.
Journal of the American Heart Association|December 23, 2025
Bio-Adrenomedullin Predicts Death and Major Adverse Cardiovascular Events in Cardiac Amyloidosis: A Cross-Continental Multicenter StudyMaximilian L Müller, Fabian Knebel, Katrin Hahn, et al.
Pageof 9